Long-Chain Polyunsaturated Fatty Acids (LCPUFAs) and the Developing Immune System: A Narrative Review
Open accessThe DOI matches its Crossref record; 107 of the 107 references it cites were found in a registry or an index.
Abstract
The immune system is complex: it involves many cell types and numerous chemical mediators. An immature immune response increases susceptibility to infection, whilst imbalances amongst immune components leading to loss of tolerance can result in immune-mediated diseases including food allergies. Babies are born with an immature immune response. The immune system develops in early life and breast feeding promotes immune maturation and protects against infections and may protect against allergies. The long-chain polyunsaturated fatty acids (LCPUFAs) arachidonic acid (AA) and docosahexaenoic acid (DHA) are considered to be important components of breast milk. AA, eicosapentaenoic acid (EPA) and DHA are also present in the membranes of cells of the immune system and act through multiple interacting mechanisms to influence immune function. The effects of AA and of mediators derived from AA are often different from the effects of the n-3 LCPUFAs (i.e., EPA and DHA) and of mediators derived from them. Studies of supplemental n-3 LCPUFAs in pregnant women show some effects on cord blood immune cells and their responses. These studies also demonstrate reduced sensitisation of infants to egg, reduced risk and severity of atopic dermatitis in the first year of life, and reduced persistent wheeze and asthma at ages 3 to 5 years, especially in children of mothers with low habitual intake of n-3 LCPUFAs. Immune markers in preterm and term infants fed formula with AA and DHA were similar to those in infants fed human milk, whereas those in infants fed formula without LCPUFAs were not. Infants who received formula plus LCPUFAs (both AA and DHA) showed a reduced risk of allergic disease and respiratory illness than infants who received standard formula. Studies in which infants received n-3 LCPUFAs report immune differences from controls that suggest better immune maturation and they show lower risk of allergic disease and respiratory illness over the first years of life. Taken together, these findings suggest that LCPUFAs play a role in immune development that is of clinical significance, particularly with regard to allergic sensitisation and allergic manifestations including wheeze and asthma.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Endres, S., Ghorbani, R., Kelley, V. E., Georgilis, K., Lonnemann, G., van der Meer, J. W. M., Cannon, J. G., Rogers, T. S., Klempner, M. S., Weber, P. C., et al. (1989) · New England Journal of Medicine · doi:10.1056/nejm198902023200501 · Cited by 1,910
Evolution of the immune system in humans from infancy to old age
Simon, A. K., Hollander, G. A., & McMichael, A. (2015) · Proceedings of the Royal Society B: Biological Sciences · doi:10.1098/rspb.2014.3085 · Cited by 1,796 · cited 1×
“The newborn’s immune system 127 develops over the course of months to a few years with acquisition of T cell and B cell 128 function and antibody production and the establishment of balances between Th1 and 129 Th2 cells and between these effector T cells and regulatory T cells [9].”
BackgroundMarine omega-3 fatty acids and inflammatory processes: effects, mechanisms and clinical relevance
Calder, P. C. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.08.010 · Cited by 1,717 · cited 9×
“Although many of the actions of PGE2 are clearly pro-inflammatory and pro-allergic, it suppresses 5-LOX, inhibiting synthesis of LTs (which are generally pro-inflammatory: see below) and induces 15-LOX to promote the synthesis of pro-resolution lipoxins [33,34].”
MethodInfluentialSelf-citationRegulation of Immune Responses by Prostaglandin E2
Kalinski, P. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1101029 · Cited by 1,474 · cited 3×
“PGE2 also inhibits natural killer cell activity [29,30].”
BackgroundLipid mediator class switching during acute inflammation: signals in resolution
Levy, B. D., Clish, C. B., Schmidt, B., Gronert, K., & Serhan, C. N. (2001) · Nature Immunology · doi:10.1038/89759 · Cited by 1,453 · cited 1×
“Although many of the actions of PGE2 are clearly pro-inflammatory and pro-allergic, it suppresses 5-LOX, inhibiting synthesis of LTs (which are generally pro-inflammatory: see below) and induces 15-LOX to promote the synthesis of pro-resolution lipoxins [33,34].”
BackgroundAnatomical basis of tolerance and immunity to intestinal antigens
Mowat, A. M. (2003) · Nature Reviews Immunology · doi:10.1038/nri1057 · Cited by 1,415 · cited 1×
“It is estimated that in humans 70% of immune cells are 110 associated with the GI tract, mainly in discrete structures such as lamina propria and 111 Peyer’s patches [3].”
BackgroundLee, T. H., Hoover, R. L., Williams, J. D., Sperling, R. I., Ravalese, J., Spur, B. W., Robinson, D. R., Corey, E. J., Lewis, R. A., & Austen, K. F. (1985) · New England Journal of Medicine · doi:10.1056/nejm198505093121903 · Cited by 1,333
Functional Roles of Fatty Acids and Their Effects on Human Health
Calder, P. C. (2015) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607115595980 · Cited by 1,160 · cited 5×
“Hence, LCPUFAs modulate intracellular signalli g within immune cells ultimately affecting trans ription f ctor activation and gene expression [23] (Figure 4).”
BackgroundInfluentialSelf-citationHuman breast milk: A review on its composition and bioactivity
Andreas, N. J., Kampmann, B., & Mehring Le-Doare, K. (2015) · Early Human Development · doi:10.1016/j.earlhumdev.2015.08.013 · Cited by 1,127 · cited 1×
“Human breast milk contains immune cells (neutrophils, macrophages, and T and B 154 cells) and numerous immune‐active molecules and immune maturation factors [8,13,14].”
BackgroundLipoxygenase and leukotriene pathways: biochemistry, biology, and roles in disease
Haeggström, J. Z., & Funk, C. D. (2011) · Chemical Reviews · doi:10.1021/cr200246d · Cited by 875 · cited 2×
“Cysteinyl‐LTs enhance vascular permeability, promote eosinophil recruitment to 283 the airways and are potent inducers of smooth muscle contraction, including in the air‐ 284 ways (bronchoconstriction) where they have a role in asthma [28,41,42,44,47].”
BackgroundSankar, M. J., Sinha, B., Chowdhury, R., Bhandari, N., Taneja, S., Martines, J., & Bahl, R. (2015) · Acta Paediatrica · doi:10.1111/apa.13147 · Cited by 849 · cited 1×
“Breast feeding protects against childhood infections [17] and may protect against childhood allergies and asthma [18], and part of this protection seems likely to be due to optimised immune development in breast-fed infants.”
BackgroundMixed messages: modulation of inflammation and immune responses by prostaglandins and thromboxanes
Tilley, S. L., Coffman, T. M., & Koller, B. H. (2001) · Journal of Clinical Investigation · doi:10.1172/jci200113416 · Cited by 726
Mixed messages: modulation of inflammation and immune responses by prostaglandins and thromboxanes
Tilley, S. L., Coffman, T. M., & Koller, B. H. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13416 · Cited by 725 · cited 2×
“PGE2 is also directly involved in inflammation where it has pro-inflammatory roles such as inducing fever and pain and enhancing vascular permeability, which allows neutrophils and macrophages to enter sites of infection or inflammation [27,28].”
BackgroundDocosahexaenoic and arachidonic acid concentrations in human breast milk worldwide
Brenna, J. T., Varamini, B., Jensen, R. G., Diersen-Schade, D. A., Boettcher, J. A., & Arterburn, L. M. (2007) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/85.6.1457 · Cited by 662
The resolution code of acute inflammation: Novel pro-resolving lipid mediators in resolution
Serhan, C. N., Chiang, N., & Dalli, J. (2015) · Seminars in Immunology · doi:10.1016/j.smim.2015.03.004 · Cited by 583
Dunstan, J. A., Mori, T. A., Barden, A., Beilin, L. J., Taylor, A. L., Holt, P. G., & Prescott, S. L. (2003) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2003.09.009 · Cited by 520 · cited 1×
“07 g DHA daily from week 20 of pregnancy [71].”
Background5-Lipoxygenase, a key enzyme for leukotriene biosynthesis in health and disease
Rådmark, O., Werz, O., Steinhilber, D., & Samuelsson, B. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.08.012 · Cited by 502 · cited 2×
“LTB4 is a bronchoconstrictor, increases vascular permeability and acts as a strong chemoattractant, acting to recruit leukocytes (especially neutrophils and macrophages) to sites of inflammatory or immune activity [28,41,42,46].”
BackgroundWang, W., Sung, N., Gilman-Sachs, A., & Kwak-Kim, J. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.02025 · Cited by 494
Fish Oil–Derived Fatty Acids in Pregnancy and Wheeze and Asthma in Offspring
Bisgaard, H., Stokholm, J., Chawes, B. L., Vissing, N. H., Bjarnadóttir, E., Schoos, A.-M. M., Wolsk, H. M., Pedersen, T. M., Vinding, R. K., Thorsteinsdóttir, S., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1503734 · Cited by 456 · cited 6×
“The beneficial effect of maternal n-3 LCPUFAs on offspring persistent wheeze or asthma was seen mainly in the subset of children whose mothers had the lowest EPA + DHA status at study entry and was less apparent in the subset of children whose mothers had the highest EPA + DHA status at study entry [86].”
BackgroundMethodInfluentialVery long-chain n -3 fatty acids and human health: fact, fiction and the future
Calder, P. C. (2018) · Proceedings of the Nutrition Society · doi:10.1017/s0029665117003950 · Cited by 419
Self-citationGoodnight, S. J., Harris, W., & Connor, W. (1981) · Blood · doi:10.1182/blood.v58.5.880.880 · Cited by 405
Rees, D., Miles, E. A., Banerjee, T., Wells, S. J., Roynette, C. E., Wahle, K. W., & Calder, P. C. (2006) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/83.2.331 · Cited by 401 · cited 3×
“This occurs partly as a result of reduced substrate (AA) availability because the n-3 LCPUFAs partially replace AA in cell membranes [21,22].”
BackgroundSelf-citationSperling, R. I., Benincaso, A. I., Knoell, C. T., Larkin, J. K., Austen, K. F., & Robinson, D. R. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116245 · Cited by 349
The Th1:Th2 Dichotomy of Pregnancy and Preterm Labour
Sykes, L., MacIntyre, D. A., Yap, X. J., Teoh, T. G., & Bennett, P. R. (2012) · Mediators of Inflammation · doi:10.1155/2012/967629 · Cited by 337 · cited 1×
“Pregnancy is associated with immune changes in the mother with a dampening of T-helper 1 (Th1)-type responses in favour of T-helper 2 (Th2)-type responses [6,7]; this is to assure maternal tolerance of the foetus.”
BackgroundResolution phase lipid mediators of inflammation: agonists of resolution
Serhan, C. N., & Chiang, N. (2013) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2013.05.012 · Cited by 331 · cited 1×
“Similarly, LTB4 is 297 10‐ to 100‐fold more potent as a leukocyte chemoattractant than LTB5 is [54,55].”
BackgroundCalder, P. C. (2020) · Essays in Biochemistry · doi:10.1042/ebc20190083 · Cited by 321
Self-citationBrowning, L. M., Walker, C. G., Mander, A. P., West, A. L., Madden, J., Gambell, J. M., Young, S., Wang, L., Jebb, S. A., & Calder, P. C. (2012) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.112.041343 · Cited by 314 · cited 1×
“Increased intake of EPA and DHA leads to increased amounts of EPA and DHA in immune cells [21,22,66,67], to increased production of SPMs and to higher concentrations of a number of SPMs in the bloodstream (reviewed recently in [68]), although this has not yet been clearly demonstrated in pregnancy or infancy.”
BackgroundSelf-citationYaqoob, Pala, Cortina‐Borja, Newsholme, & Calder (2000) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2000.00623.x · Cited by 308 · cited 3×
“This occurs partly as a result of reduced substrate (AA) availability because the n-3 LCPUFAs partially replace AA in cell membranes [21,22].”
BackgroundLee, T. H., Menica-Huerta, J. M., Shih, C., Corey, E. J., Lewis, R. A., & Austen, K. F. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)43363-1 · Cited by 304 · cited 1×
“Similarly, LTB4 is 10- to 100-fold more potent as a leukocyte chemoattractant than LTB5 is [54,55].”
BackgroundGoldman, D. W., Pickett, W. C., & Goetzl, E. J. (1983) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(83)91572-3 · Cited by 294 · cited 1×
“Similarly, LTB4 is 10- to 100-fold more potent as a leukocyte chemoattractant than LTB5 is [54,55].”
BackgroundDietary fatty acids and the immune system
Calder, P. C. (1999) · Lipids · doi:10.1007/bf02562264 · Cited by 276
Self-citationPalmer, D. J., Sullivan, T., Gold, M. S., Prescott, S. L., Heddle, R., Gibson, R. A., & Makrides, M. (2012) · BMJ · doi:10.1136/bmj.e184 · Cited by 271 · cited 2×
“There was also a strong trend to less IgE-associated eczema, but there was no difference in “any IgE-mediated disease” [83].”
Prevention of asthma during the first 5 years of life: A randomized controlled trial
Marks, G. B., Mihrshahi, S., Kemp, A. S., Tovey, E. R., Webb, K., Almqvist, C., Ampon, R. D., Crisafulli, D., Belousova, E. G., Mellis, C. M., et al. (2006) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2006.04.004 · Cited by 269
Kane, S. V., & Acquah, L. A. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2008.71 · Cited by 267 · cited 1×
“Importantly therefore, the pregnant mother provides passive immunity to the foetus through placental transfer of antibodies [5].”
BackgroundFish oil supplementation in pregnancy and lactation may decrease the risk of infant allergy
Furuhjelm, C., Warstedt, K., Larsson, J., Fredriksson, M., Böttcher, M. F., Fälth‐Magnusson, K., & Duchén, K. (2009) · Acta Paediatrica · doi:10.1111/j.1651-2227.2009.01355.x · Cited by 264 · cited 4×
“Studies using the combination of EPA + DHA used supplements where EPA predominated [74,75,81,82,86] or where DHA predominated [69–73,83–85].”
BackgroundMethodInfluentialMolecular mechanisms underlying prostaglandin E2-exacerbated inflammation and immune diseases
Tsuge, K., Inazumi, T., Shimamoto, A., & Sugimoto, Y. (2019) · International Immunology · doi:10.1093/intimm/dxz021 · Cited by 263 · cited 1×
“PGE2 induces differentiation of pro-inflammatory T-helper 17 cells [32].”
BackgroundSerhan, C. N. (2017) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2017.03.001 · Cited by 257
The Immature Gut Barrier and Its Importance in Establishing Immunity in Newborn Mammals
Weström, B., Arévalo Sureda, E., Pierzynowska, K., Pierzynowski, S. G., & Pérez-Cano, F.-J. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01153 · Cited by 252 · cited 1×
“Some of these factors are also involved in promoting a healthy gut microbiota and the codevelopment of a healthy gut microbiota and a well-functioning immune system seems likely to be promoted through the dual action of breast milk derived factors [11,12,15,16].”
BackgroundNew pro-resolving n-3 mediators bridge resolution of infectious inflammation to tissue regeneration
Serhan, C. N., Chiang, N., & Dalli, J. (2018) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2017.08.002 · Cited by 245 · cited 1×
“Several SPMs also promote aspects of innate immunity including phagocytosis of bacteria and of cellular debris [59].”
BackgroundOlsen, S. F., Østerdal, M. L., Salvig, J. D., Mortensen, L. M., Rytter, D., Secher, N. J., & Henriksen, T. B. (2008) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/88.1.167 · Cited by 235 · cited 4×
“Studies using the combination of EPA + DHA used supplements where EPA predominated [74,75,81,82,86] or where DHA predominated [69–73,83–85].”
BackgroundMethodInfluentialEffect of low-to-moderate amounts of dietary fish oil on neutrophil lipid composition and function
Healy, D. A., Wallace, F. A., Miles, E. A., Calder, P. C., & Newsholme, P. (2000) · Lipids · doi:10.1007/s11745-000-0583-1 · Cited by 227 · cited 1×
“Increased intake of EPA and DHA leads to increased amounts of EPA and DHA in immune cells [21,22,66,67], to increased production of SPMs and to higher concentrations of a number of SPMs in the bloodstream (reviewed recently in [68]), although this has not yet been clearly demonstrated in pregnancy or infancy.”
BackgroundSelf-citationPeat, J. K., Mihrshahi, S., Kemp, A. S., Marks, G. B., Tovey, E. R., Webb, K., Mellis, C. M., & Leeder, S. R. (2004) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2004.06.057 · Cited by 221
Oxidation of polyunsaturated fatty acids to produce lipid mediators
Christie, W. W., & Harwood, J. L. (2020) · Essays in Biochemistry · doi:10.1042/ebc20190082 · Cited by 216 · cited 3×
“Perhaps the best described function of LCPUFAs with regard to immune function, including the inflammatory component, is their role as substrates for the generation of bioactive lipid mediators [25,26] (Figure 5).”
BackgroundInfluentialDunstan, J. A., Mori, T. A., Barden, A., Beilin, L. J., Taylor, A. L., Holt, P. G., & Prescott, S. L. (2003) · Clinical & Experimental Allergy · doi:10.1046/j.1365-2222.2003.01590.x · Cited by 209
Breastfeeding, Childhood Asthma, and Allergic Disease
Oddy, W. H. (2017) · Annals of Nutrition and Metabolism · doi:10.1159/000457920 · Cited by 206 · cited 1×
“166 Breast feeding protects against childhood infections [17] and may protect against child‐ 167 hood allergies and asthma [18], and part of this protection seems likely to be due to opti‐ 168 mised immune development in breast‐fed infants.”
BackgroundMihrshahi, S., Peat, J. K., Marks, G. B., Mellis, C. M., Tovey, E. R., Webb, K., Britton, W. J., & Leeder, S. R. (2003) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2003.36 · Cited by 203
Calder, P. C., Bevan, S. J., & Newsholme, E. A. (1992) · PubMed · Cited by 174
Self-citationAuthority, E. F. S. (2010) · EFSA Journal · doi:10.2903/j.efsa.2010.1507 · Cited by 171
Development of immunity in early life
Goenka, A., & Kollmann, T. R. (2015) · Journal of Infection · doi:10.1016/j.jinf.2015.04.027 · Cited by 167 · cited 1×
“Never‐ 115 theless, fetal immune cells are immature with limited functionality [4].”
BackgroundFuruhjelm, C., Warstedt, K., Fagerås, M., Fälth‐Magnusson, K., Larsson, J., Fredriksson, M., & Duchén, K. (2011) · Pediatric Allergy and Immunology · doi:10.1111/j.1399-3038.2010.01096.x · Cited by 166 · cited 3×
“Studies using the combination of EPA + DHA used supplements where EPA predominated [74,75,81,82,86] or where DHA predominated [69–73,83–85].”
BackgroundMethodCalder, P. C. (2020) · Biochimie · doi:10.1016/j.biochi.2020.08.015 · Cited by 165 · cited 1×
“Increased intake of EPA and DHA leads to increased amounts of EPA and DHA in immune cells [21,22,66,67], to increased production of SPMs and to higher concentrations of a number of SPMs in the bloodstream (reviewed recently in [68]), although this has not yet been clearly demonstrated in pregnancy or infancy.”
BackgroundSelf-citationInfluence of Maternal Milk on the Neonatal Intestinal Microbiome
Gopalakrishna, K. P., & Hand, T. W. (2020) · Nutrients · doi:10.3390/nu12030823 · Cited by 165 · cited 1×
“Some of these factors are also involved in promoting a healthy gut microbiota and 159 the co‐development of a healthy gut microbiota and a well‐functioning immune system 160 seems likely to be promoted through the dual action of breast milk derived factors 161 [11,12,15,16].”
BackgroundThe Role of Leukotrienes as Potential Therapeutic Targets in Allergic Disorders
Jo‐Watanabe, A., Okuno, T., & Yokomizo, T. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20143580 · Cited by 165
Krauss-Etschmann, S., Hartl, D., Rzehak, P., Heinrich, J., Shadid, R., del Carmen Ramírez-Tortosa, M., Campoy, C., Pardillo, S., Schendel, D. J., Decsi, T., et al. (2008) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.09.018 · Cited by 160 · cited 2×
“[69] From week 22 of pregnancy until birth EPA 0.”
BackgroundLee, H., Barraza‐Villarreal, A., Hernández‐Vargas, H., Sly, P. D., Biessy, C., Ramakrishnan, U., Romieu, I., & Herceg, Z. (2013) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.112.052241 · Cited by 159 · cited 1×
“The effects of maternal n-3 LCPUFAs observed in some studies may relate to epigenetic differences, as reported for cord blood immune cells in some studies [89] though not in others [90].”
BackgroundD’Vaz, N., Meldrum, S. J., Dunstan, J. A., Martino, D., McCarthy, S., Metcalfe, J. R., Tulić, M. K., Mori, T. A., & Prescott, S. L. (2012) · PEDIATRICS · doi:10.1542/peds.2011-3104 · Cited by 151
Field, C. J., Thomson, C. A., Van Aerde, J. E., Parrott, A., Euler, &., Lien, E., & Clandinin, M. T. (2000) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/00005176-200009000-00017 · Cited by 149 · cited 2×
“[93] compared human milk with standard formula or standard formula with added AA (0.”
ResultThe Importance of Human Milk for Immunity in Preterm Infants
Lewis, E. D., Richard, C., Larsen, B. K., & Field, C. J. (2016) · Clinics in Perinatology · doi:10.1016/j.clp.2016.11.008 · Cited by 148 · cited 2×
“Human breast milk contains immune cells (neutrophils, macrophages, and T and B 154 cells) and numerous immune‐active molecules and immune maturation factors [8,13,14].”
BackgroundAlmqvist, C., Garden, F. L., Xuan, W., Mihrshahi, S., Leeder, S., Oddy, W. H., Webb, K., & Marks, G. B. (2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.01.046 · Cited by 144
Cysteinyl Leukotriene Receptor-1 Antagonists as Modulators of Innate Immune Cell Function
Theron, A. J., Steel, H. C., Tintinger, G. R., Gravett, C. M., Anderson, R., & Feldman, C. H. (2014) · Journal of Immunology Research · doi:10.1155/2014/608930 · Cited by 132 · cited 1×
“Cysteinyl-LTs enhance vascular permeability, promote eosinophil recruitment to the airways and are potent inducers of smooth muscle contraction, including in the airways (bronchoconstriction) where they have a role in asthma [28,41,42,44,47].”
BackgroundHuman milk proresolving mediators stimulate resolution of acute inflammation
Arnardottir, H., Orr, S. K., Dalli, J., & Serhan, C. N. (2016) · Mucosal Immunology · doi:10.1038/mi.2015.99 · Cited by 131
PGD Synthase and PGD 2 in Immune Resposne
Joo, M., & Sadikot, R. T. (2012) · Mediators of Inflammation · doi:10.1155/2012/503128 · Cited by 126 · cited 2×
“In parallel studies in mice, stabilization of PGE2 concentrations pro‐ 254 tected against anaphylaxis [37].”
BackgroundWeiss, G. A., Troxler, H., Klinke, G., Rogler, D., Braegger, C., & Hersberger, M. (2013) · Lipids in Health and Disease · doi:10.1186/1476-511x-12-89 · Cited by 120
Fish oil supplementation during pregnancy and allergic respiratory disease in the adult offspring
Hansen, S., Strøm, M., Maslova, E., Dahl, R., Hoffmann, H. J., Rytter, D., Bech, B. H., Henriksen, T. B., Granström, C., Halldorsson, T. I., et al. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.02.042 · Cited by 116 · cited 4×
“[81,82] From week 30 of preg‐ nancy until birth EPA 1.”
BackgroundMethodInfluentialRogier, E. W., Frantz, A. L., Bruno, M. E. C., Wedlund, L., Cohen, D. A., Stromberg, A. J., & Kaetzel, C. S. (2014) · Gut Microbes · doi:10.4161/19490976.2014.969984 · Cited by 114 · cited 1×
“Some of these factors are also involved in promoting a healthy gut microbiota and the codevelopment of a healthy gut microbiota and a well-functioning immune system seems likely to be promoted through the dual action of breast milk derived factors [11,12,15,16].”
BackgroundFish Oil Supplementation Modulates Immune Function in Healthy Infants
Damsgaard, C. T., Lauritzen, L., Kjær, T., Holm, P. M. I., Fruekilde, M., Michaelsen, K. F., & Frøkiær, H. (2007) · Journal of Nutrition · doi:10.1093/jn/137.4.1031 · Cited by 110
Birch, E. E., Khoury, J. C., Berseth, C. L., Castañeda, Y. S., Couch, J. M., Bean, J. A., Tamer, R. M., Harris, C. L., Mitmesser, S. H., & Scalabrin, D. (2010) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2010.01.002 · Cited by 110 · cited 1×
“[95] followed up term infants who had received standard formula or formula + LCPUFAs (AA 0.”
Endogenous Anti-inflammatory Mediators from Arachidonate in Human Neutrophils
Vachier, I., Chanez, P., Bonnans, C., Godard, P., Bousquet, J. J., & Chavis, C. (2002) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.6155 · Cited by 107 · cited 1×
“Although many of the actions of PGE2 are clearly pro-inflammatory and pro-allergic, it suppresses 5-LOX, inhibiting synthesis of LTs (which are generally pro-inflammatory: see below) and induces 15-LOX to promote the synthesis of pro-resolution lipoxins [33,34].”
BackgroundCysteinyl leukotriene receptors, old and new; implications for asthma
Laidlaw, T. M., & Boyce, J. A. (2012) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2012.03982.x · Cited by 107 · cited 2×
“LTB4 is a bronchoconstrictor, increases vascular permeability and acts as a strong 270 chemoattractant, acting to recruit leukocytes (especially neutrophils and macrophages) to 271 sites of inflammatory or immune activity [28,41,42,46].”
BackgroundDevelopment of Microbiota in Infants and its Role in Maturation of Gut Mucosa and Immune System
Ximénez, C., & Torres, J. (2017) · Archives of Medical Research · doi:10.1016/j.arcmed.2017.11.007 · Cited by 107
Denburg, J. A., Hatfield, H. M., Cyr, M. M., Hayes, L., Holt, P. G., Sehmi, R., Dunstan, J. A., & Prescott, S. L. (2004) · Pediatric Research · doi:10.1203/01.pdr.0000148279.72611.1d · Cited by 105
Effect of omega‐3 fatty acid concentrations in plasma on symptoms of asthma at 18 months of age
Mihrshahi, S., Peat, J. K., Webb, K., Oddy, W. H., Marks, G. B., Mellis, C. M., & the CAPS Team (2004) · Pediatric Allergy and Immunology · doi:10.1111/j.1399-3038.2004.00187.x · Cited by 104
The prostaglandin D2 receptor 2 pathway in asthma: a key player in airway inflammation
Domingo, C., Palomares, Ó., Sandham, D. A., Erpenbeck, V. J., & Altman, P. (2018) · Respiratory Research · doi:10.1186/s12931-018-0893-x · Cited by 104 · cited 1×
“It has a significant pro-inflammatory effect that is prominent in allergic airways disease (asthma), where it up-regulates some of the distinct characteristics including eosinophilia, airway hyperreactivity, production of mucus, and production of Th2-type cytokines [39].”
BackgroundResolvin D4 stereoassignment and its novel actions in host protection and bacterial clearance
Winkler, J. W., Orr, S. K., Dalli, J., Cheng, C.-Y. C., Sanger, J. M., Chiang, N., Petasis, N. A., & Serhan, C. N. (2016) · Scientific Reports · doi:10.1038/srep18972 · Cited by 99
Fish oil supplementation of lactating mothers affects cytokine production in 2 1/2‐year‐old children
Lauritzen, L., Kjær, T. M. R., Fruekilde, M., Michaelsen, K. F., & Frøkiær, H. (2005) · Lipids · doi:10.1007/s11745-005-1429-6 · Cited by 98 · cited 2×
“[91] First 4 months of lactation EPA plus DHA 1.”
BackgroundRandomized controlled trial of fish oil supplementation in pregnancy on childhood allergies
Palmer, D. J., Sullivan, T., Gold, M., Prescott, S. L., Heddle, R., Gibson, R. A., & Makrides, M. (2013) · Allergy · doi:10.1111/all.12233 · Cited by 97 · cited 1×
“These infants were followed up at age 3 years: there was no effect of the DHA-rich oil on any clinical outcome including asthma [84].”
BackgroundFish oil supplementation in early infancy modulates developing infant immune responses
D'Vaz, N., Meldrum, S. J., Dunstan, J. A., Lee‐Pullen, T. F., Metcalfe, J., Holt, B. J., Serralha, M., Tulic, M. K., Mori, T. A., & Prescott, S. L. (2012) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2012.04031.x · Cited by 96 · cited 2×
“LCPUFAs re‐ 471 duced wheeze/asthma in infants of allergic mothers [98].”
BackgroundPrenatal Fish Oil Supplementation and Allergy: 6-Year Follow-up of a Randomized Controlled Trial
Best, K. P., Sullivan, T., Palmer, D. J., Gold, M., Kennedy, D., Martin, J. A., & Makrides, M. (2016) · PEDIATRICS · doi:10.1542/peds.2015-4443 · Cited by 94 · cited 1×
“However, at age 6 years sensitisation to one species of house dust mite was lower in the DHA group than in the control group [85].”
BackgroundField, C. J., Aerde, J. E. V., Robinson, L. E., & Clandinin, M. T. (2007) · British Journal Of Nutrition · doi:10.1017/s0007114507791845 · Cited by 81
Brudvik, K. W., & Taskén, K. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01800.x · Cited by 76 · cited 3×
“PGD2 also has effects within acquired immunity but these are not well described, although, like PGE2, it has been reported to suppress the Th1-mediated response [30].”
BackgroundImportance of the leukotriene B4-BLT1 and LTB4-BLT2 pathways in asthma
Gelfand, E. W. (2017) · Seminars in Immunology · doi:10.1016/j.smim.2017.08.005 · Cited by 73 · cited 2×
“LTB4 is a bronchoconstrictor, increases vascular permeability and acts as a strong chemoattractant, acting to recruit leukocytes (especially neutrophils and macrophages) to sites of inflammatory or immune activity [28,41,42,46].”
BackgroundFormula with long‐chain polyunsaturated fatty acids reduces incidence of allergy in early childhood
Foiles, A. M., Kerling, E. H., Wick, J., Scalabrin, D., Colombo, J. A., & Carlson, S. E. (2015) · Pediatric Allergy and Immunology · doi:10.1111/pai.12515 · Cited by 68 · cited 2×
“[98] followed-up a subset of infants who had been involved in a trial of different infant formulas for the first 12 months of their life.”
BackgroundPastor, N., Soler, B., Mitmesser, S. H., Ferguson, P., & Lifschitz, C. (2006) · Clinical Pediatrics · doi:10.1177/1073858406289801 · Cited by 67 · cited 1×
“In another study [96], term infants received standard formula or formula + LCPUFAs (AA 0.”
BackgroundPrenatal Docosahexaenoic Acid Supplementation and Infant Morbidity: Randomized Controlled Trial
Imhoff-Kunsch, B., Stein, A. D., Martorell, R., Parra-Cabrera, S., Romieu, I., & Ramakrishnan, U. (2011) · Pediatrics · doi:10.1542/peds.2010-1386 · Cited by 67 · cited 3×
“[87,88] From weeks 18 to 22 of pregnancy until birth DHA 0.”
BackgroundResultPrescott, S. L., Barden, A. E., Mori, T. A., & Dunstan, J. A. (2007) · Clinical Science · doi:10.1042/cs20070111 · Cited by 66
Warstedt, K., Furuhjelm, C., Duchén, K., Fälth‐Magnusson, K., & Fagerås, M. (2009) · Pediatric Research · doi:10.1203/pdr.0b013e3181aabd1c · Cited by 66 · cited 1×
“1 g DHA daily) during both pregnancy and lactation resulted in lower PGE2 production by stimulated maternal blood collected within one week of birth [92].”
BackgroundProstanoids and leukotrienes in the pathophysiology of atopic dermatitis and psoriasis
Honda, T., & Kabashima, K. (2019) · International Immunology · doi:10.1093/intimm/dxy087 · Cited by 64 · cited 1×
“It has a significant pro‐inflammatory effect that is prominent in allergic airways 259 disease (asthma), where it up‐regulates some of the distinct characteristics including eo‐ 260 sinophilia, airway hyperreactivity, production of mucus, and production of Th2‐type cy‐ 261 tokines [39].”
BackgroundLactation and Intestinal Microbiota: How Early Diet Shapes the Infant Gut
Goldsmith, F., O’Sullivan, A. M., Smilowitz, J. T., & Freeman, S. L. (2015) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-015-9335-2 · Cited by 63 · cited 1×
“Some of these factors are also involved in promoting a healthy gut microbiota and the codevelopment of a healthy gut microbiota and a well-functioning immune system seems likely to be promoted through the dual action of breast milk derived factors [11,12,15,16].”
BackgroundLapillonne, A., Pastor, N., Zhuang, W., & Scalabrin, D. (2014) · BMC Pediatrics · doi:10.1186/1471-2431-14-168 · Cited by 59 · cited 1×
“A third study used the same comparison [97] and identified that infants who were receiving LCPUFAs were less likely to develop bronchitis or bronchiolitis, croup, nasal congestion, cough or diarrhoea requiring medical attention over the first year of life.”
ResultBrandt, S. L., & Serezani, C. H. (2017) · Seminars in Immunology · doi:10.1016/j.smim.2017.08.006 · Cited by 58
Role of lipid mediators and control of lymphocyte responses in type 2 immunopathology
Samuchiwal, S. K., & Boyce, J. A. (2018) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2018.02.006 · Cited by 56 · cited 4×
“PGE2 is also directly involved in inflammation where it has pro-inflammatory roles such as inducing fever and pain and enhancing vascular permeability, which allows neutrophils and macrophages to enter sites of infection or inflammation [27,28].”
BackgroundInfluentialOmega-3 Fatty Acid Supplementation During Pregnancy and Respiratory Symptoms in Children
Escamilla-Núñez, C., Barraza‐Villarreal, A., Cadena, L. H., Navarro-Olivos, E., Sly, P. D., & Romieu, I. (2014) · CHEST Journal · doi:10.1378/chest.13-1432 · Cited by 53 · cited 3×
“In that study, infants of atopic mothers who received DHA showed lower likelihood of respiratory illness up to age 18 months [88].”
BackgroundResultMozurkewich, E., Greenwood, M., Clinton, C. M., Berman, D. R., Romero, V., Djurić, Z., Qualls, C., & Gronert, K. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00274 · Cited by 52
Importance of Fatty Acids in the Perinatal Period
Demmelmair, H., & Koletzko, B. V. (2014) · World review of nutrition and dietetics · doi:10.1159/000365427 · Cited by 50 · cited 1×
“AA and DHA are the main LCPUFAs in human breast milk [19] and have been identified to have important roles in development of the infant visual and cognitive systems [20].”
BackgroundPGE2 deficiency predisposes to anaphylaxis by causing mast cell hyperresponsiveness
Rastogi, S., Willmes, D. M., Nassiri, M., Babina, M., & Worm, M. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.03.046 · Cited by 49
Gao, Y., Zhao, C., Wang, W., Jin, R., Li, Q., Ge, Q., Guan, Y., & Zhang, Y. (2016) · Scientific Reports · doi:10.1038/srep20505 · Cited by 48 · cited 7×
“There was also a strong trend to less IgE-associated eczema, but there was no difference in “any IgE-mediated disease” [83].”
BackgroundInfluentialAmarasekera, M., Noakes, P. S., Strickland, D. H., Saffery, R., Martino, D., & Prescott, S. L. (2014) · Epigenetics · doi:10.4161/15592294.2014.983366 · Cited by 47 · cited 1×
“The effects of maternal n-3 LCPUFAs observed in some studies may relate to epigenetic differences, as reported for cord blood immune cells in some studies [89] though not in others [90].”
BackgroundSee, V. H. L., Mas, E., Prescott, S. L., Beilin, L. J., Burrows, S., Barden, A. E., Huang, R., & Mori, T. A. (2017) · British Journal Of Nutrition · doi:10.1017/s0007114517002914 · Cited by 43 · cited 1×
“SPMs have been measured in human plasma including from pregnant women [60], umbilical cord [60–62], infants [61] and children [61,62].”
Regulation of oral antigen delivery early in life: Implications for oral tolerance and food allergy
Yokanovich, L. T., Newberry, R. D., & Knoop, K. A. (2021) · Clinical & Experimental Allergy · doi:10.1111/cea.13823 · Cited by 40 · cited 1×
“A breakdown in tolerance to such normally harmless exposures is linked to various diseases including inflammatory bowel diseases (suggested to involve loss of tolerance to commensal gut microbes [1]) and food allergies (loss of tolerance to food components [2]).”
BackgroundNordgren, T. M., Anderson‐Berry, A., Ormer, M. V., Zoucha, S., Elliott, E., Johnson, R., McGinn, E. A., Cave, C., Rilett, K., Weishaar, K., et al. (2019) · Nutrients · doi:10.3390/nu11010098 · Cited by 32 · cited 1×
“SPMs have been measured in human plasma including from pregnant women [60], umbilical cord [60–62], infants [61] and children [61,62].”
Granot, E., Jakobovich, E., Rabinowitz, R., Levy, P., & Schlesinger, M. (2011) · Mediators of Inflammation · doi:10.1155/2011/493925 · Cited by 30 · cited 6×
“LCPUFA intervention as early as 12 weeks of pregnancy [80] or as late as 30 weeks of pregnancy [81,82], although most started between weeks 18 and 25 (Table 2).”
BackgroundResultInfluentialEffect of prenatal EPA and DHA on maternal and umbilical cord blood cytokines
Mozurkewich, E., Berman, D. R., Vahratian, A. M., Clinton, C. M., Romero, V., Chilimigras, J. L., Vázquez, D. M., Qualls, C., & Djurić, Z. (2018) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-018-1899-6 · Cited by 27 · cited 4×
“[74,75] From week 25 of preg‐ nancy until week 15 of lactation EPA 1.”
BackgroundMethodInfluentialRusznak, M., & Peebles, R. S. (2018) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0000000000000498 · Cited by 27 · cited 1×
“Since PGE2 normally prevents excess production of LTs, inhibition of PGE2 production by aspirin and other non-steroidal anti-inflammatory drugs permits over-production of the LTs involved in respiratory inflammation [36].”
BackgroundSee, V. H. L., Mas, E., Prescott, S. L., Beilin, L. J., Burrows, S., Barden, A. E., Huang, R., & Mori, T. A. (2017) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2017.08.008 · Cited by 17 · cited 1×
“SPMs have been measured in human plasma including from pregnant women [60], umbilical cord [60–62], infants [61] and children [61,62].”
Romero, V., Somers, E. C., Stolberg, V. R., Clinton, C. M., Chensue, S. W., Djurić, Z., Berman, D. R., Treadwell, M. C., Vahratian, A. M., & Mozurkewich, E. (2013) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2013.01.024 · Cited by 17
Immunology of Human Milk and Lactation: Historical Overview
Ogra, P. L. O. (2020) · Nestlé Nutrition Institute Workshop series · doi:10.1159/000505211 · Cited by 14 · cited 3×
“Similarly the total number of immune cells in human breast milk is highest in colostrum and early milk [14].”
BackgroundInfluentialHost immune interactions in chronic inflammatory gastrointestinal conditions
Caminero, A., & Pinto-Sánchez, M. I. (2020) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000673 · Cited by 10 · cited 1×
“A breakdown in tolerance to such normally harmless exposures is linked to various diseases including inflammatory bowel diseases (suggested to involve loss of tolerance to commensal gut microbes [1]) and food allergies (loss of tolerance to food components [2]).”
Background
Cited by
Cerasuolo, M., Di Meo, I., Auriemma, M. C., Paolisso, G., Papa, M., & Rizzo, M. R. (2024) · Biomolecules · doi:10.3390/biom14111362 · Cited by 47
Altered lipid metabolism as a predisposing factor for liver metastasis in MASLD
Kim, S. J., & Hyun, J. (2024) · Molecules and Cells · doi:10.1016/j.mocell.2024.100010 · Cited by 30
Metadata
- Authors
- Miles, E. A., Childs, C. E., & Calder, P. C.
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2021-01-16
- Volume
- 13
- Issue
- 1
- Pages
- 247
- ISSN
- 2072-6643 (ISSN-L)
- OpenAlex
- W3125110155
- Cited by
- 177
- References
- 107
- FWCI
- 6.05
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.